(Q39758113)

14 September 2017

1 reference

title

Haloperidol decanoate. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in psychosis (English)

1 reference

14 September 2017

1 reference

1 reference

1 reference

1 reference

R Beresford

1

1 reference

PubMed ID

3545764

14 September 2017

A Ward

series ordinal

2

1 reference

14 September 2017

1 January 1987

1 reference

14 September 2017

1 reference

14 September 2017

33

1 reference

14 September 2017

1

1 reference

14 September 2017

31-49

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-198733010-00002

14 September 2017

0 references

cites work

The use of depot neuroleptic haloperidol decanoate

1 reference

12 December 2020

A clinical trial comparing intramuscular haloperidol decanoate and oral haloperidol in chronic schizophrenic patients: efficacy, safety, and dosage equivalence.

1 reference

12 December 2020

Influence of route of administration on haloperidol plasma levels in psychotic patients

1 reference

12 December 2020

Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis.

1 reference

12 December 2020

Double-blind comparison of haloperidol decanoate and fluphenazine decanoate effectiveness, side-effects, dosage and serum levels during a six months' treatment for relapse prevention.

1 reference

12 December 2020

Differential effects of haloperidol decanoate, a long-acting neuroleptic, in behavioral and biochemical tests.

1 reference

12 December 2020

Haloperidol decanoate in schizophreniform disorders. Clinical and neuroendocrine aspects

1 reference

12 December 2020

A double-blind, controlled clinical trial of haloperidol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia

1 reference

12 December 2020

Theoretical and practical importance of plasma levels of haloperidol. Correlations with clinical and computerized EEG data

1 reference

12 December 2020

A controlled study of haloperidol in chronic schizophrenia

1 reference

12 December 2020

Pharmacokinetic of haloperidol decanoate in psychotic patients (author's transl)

1 reference

12 December 2020

A review of clinical literature on haloperidol

1 reference

12 December 2020

Tolerance and serum levels of haloperidol during parenteral and oral haloperidol treatment in geriatric patients

1 reference

12 December 2020

Excretion and metabolism of intramuscularly administered [14C]-haloperidol decanoate in rats.

1 reference

12 December 2020

Pharmacokinetic studies on haloperidol in man.

1 reference

12 December 2020

12-month study of haloperidol decanoate in chronic schizophrenic patients

1 reference

12 December 2020

Neuroendocrine effects of haloperidol decanoate in patients with chronic schizophrenia.

1 reference

12 December 2020

Intramuscular haloperidol decanoate for neuroleptic maintenance therapy. Efficacy, dosage schedule and plasma levels. An open multicenter study

1 reference

12 December 2020

Oral dyskinesia in rats following brain lesions and neuroleptic drug administration

1 reference

12 December 2020

Studies on serum protein binding of haloperidol

1 reference

12 December 2020

Pharmacokinetics and therapeutic efficacy of haloperidol decanoate after loading dose administration.

1 reference

12 December 2020

Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses

1 reference

12 December 2020

Relationship of serum haloperidol levels to clinical response in schizophrenic patients

1 reference

12 December 2020

Efficacy of haloperidol in drug refractory patients

1 reference

12 December 2020

Pharmacokinetics of haloperidol decanoate. A 2-year follow-up

1 reference

12 December 2020

Prescription of controlled drugs to addicts

1 reference

12 December 2020

A model for oral dyskinesia in rats.

1 reference

12 December 2020

Intramuscular haloperidol decanoate for neuroleptic maintenance therapy

1 reference

12 December 2020

Haloperidol secreted in breast milk

1 reference

12 December 2020

Haloperidol decanoate and flupenthixol decanoate in schizophrenia. A long-term double-blind cross-over comparison.

1 reference

12 December 2020

[2 cases of Gilles de la Tourette's disease treated with haloperidol decanoate]

1 reference

12 December 2020

Haloperidol excretion in human milk

1 reference

12 December 2020

Neuroleptic malignant syndrome: successful treatment with bromocriptine

1 reference

12 December 2020

Reduction of nigral glutamic acid decarboxylase in rats with neuroleptic-induced oral dyskinesia.

1 reference

12 December 2020

10.2165/00003495-198733010-00002

Identifiers

DOI

1 reference

PubMed ID

3545764

Dimensions Publication ID

14 September 2017

0 references

1 reference

PubMed ID

3545764